相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A roadmap for biomarker qualification
David G. Warnock et al.
NATURE BIOTECHNOLOGY (2010)
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle et al.
NATURE BIOTECHNOLOGY (2010)
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function
Josef S. Ozer et al.
NATURE BIOTECHNOLOGY (2010)
Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells
F. G. Pruefer et al.
JOURNAL OF CHEMOTHERAPY (2008)
Cisplatin nephrotoxicity: A review
Xin Yao et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Cystatin C - A marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy
P. Benoehr et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2006)
Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat
A Yonezawa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
WK Han et al.
KIDNEY INTERNATIONAL (2002)
Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: Criteria, validation, strategies
LJ Lesko et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Molecular mechanisms involved in cisplatin cytotoxicity
P Jordan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
分享论文
